Arizona Sci-Tech Gazette
SEE OTHER BRANDS

Your best source on science and technology news from Arizona

Arizona Sci-Tech Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arizona Sci-Tech Gazette.

Press releases published on August 15, 2025

Aduro Clean Technologies informiert über Fortschritt der NGP-Pilotanlage

Aduro Clean Technologies informiert über Fortschritt der NGP-Pilotanlage

LONDON, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro“ oder das „Unternehmen“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen für saubere Technologien, das die Kraft der Chemie nutzt, um minderwertige Rohstoffe wie …

Aduro Clean Technologies fait le point sur la progression de son usine pilote NGP

Aduro Clean Technologies fait le point sur la progression de son usine pilote NGP

LONDON, Ontario, 15 août 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (ci-après « Aduro » ou la « Société ») (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société du secteur des technologies propres qui recycle chimiquement les matières premières …

Digitaler Kompass für gezielte Zielgruppen-Insights: vivenu stellt Customer Segments vor

Digitaler Kompass für gezielte Zielgruppen-Insights: vivenu stellt Customer Segments vor

DÜSSELDORF, Deutschland, Aug. 15, 2025 (GLOBE NEWSWIRE) -- vivenu, die führende Enterprise-Ticketingplattform für Live-Entertainment, präsentiert vivenu Customer Segments – das Feature, das grundlegend verändert, wie Veranstalter ihre Zielgruppen verstehen …

vivenu Unveils Customer Segments: Your Digital Compass to Enhanced Audience Value

vivenu Unveils Customer Segments: Your Digital Compass to Enhanced Audience Value

DÜSSELDORF, Germany, Aug. 15, 2025 (GLOBE NEWSWIRE) -- vivenu, the leading enterprise-grade ticketing platform for live entertainment, announced vivenu Customer Segments, the feature designed to transform how event organizers understand, engage with, and …

Viomi Technology Co., Ltd Announces Preliminary First Half 2025 Financial

Viomi Technology Co., Ltd Announces Preliminary First Half 2025 Financial

GUANGZHOU, China, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced its preliminary, unaudited revenue for the first half …

To “Eat” or to “Escape”? NTHU Uncovers Olfactory Code of Fruit Fly Brain

To “Eat” or to “Escape”? NTHU Uncovers Olfactory Code of Fruit Fly Brain

HSINCHU, Taiwan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Director of the Brain Research Center at National Tsing Hua University (NTHU) in Taiwan, Ann-Shyn Chiang (江安世), Professor of the Institute for Systems Neuroscience, Chung-Chuan Lo (羅中泉), and …

Santhera verlängert Wandelanleihe von Highbridge bis zum 30. September 2025

Santhera verlängert Wandelanleihe von Highbridge bis zum 30. September 2025

Ad hoc-Mitteilung gemäss Art. 53 KR Pratteln, Schweiz, 15. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass das Unternehmen und Highbridge Capital Management, LLC (Highbridge) einvernehmlich beschlossen haben, die Laufzeit der …

Santhera extends Highbridge convertible bond to 30th September 2025

Santhera extends Highbridge convertible bond to 30th September 2025

Ad hoc announcement pursuant to Art. 53 LRA Pratteln, Switzerland, 15 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that by mutual agreement the Company and Highbridge Capital Management, LLC (Highbridge) have decided to extend the maturity …

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today …

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

Breakthrough Protein Phosphatase 2A inhibitor LB-100 Targets Ovarian Clear Cell Carcinoma, Advanced Soft Tissue Sarcoma, and MSS Metastatic Colon Cancer 24/7 Market News Issues Corrected Information on Previously issued Press Release with same title DENVER …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions